Sunesis Pharmaceuticals -

About Us Products in Development Patients & Caregivers Investors & Media Partnering

Sunesis Pharmaceuticals - Inspired to Make a Difference in Cancer Patients Lives.

Sunesis In The News

Nov 30 2020
Sunesis Pharmaceuticals and Viracta Therapeutics Announce Definitive Merger Agreement

Nov 16 2020
Sunesis Pharmaceuticals Reports Third Quarter 2020 Financial Results and Recent Highlights

Nov 09 2020
Sunesis Pharmaceuticals to Host Conference Call on November 16th to Discuss Third Quarter 2020 Financial Results and Recent Highlights

Sunesis is a clinical-stage biopharmaceutical company focused on the development and commercialization of new oncology therapeutics.

With a passion to advance novel drugs, we are inspired to make a difference in cancer patients' lives!

Want to learn more about
Chronic Lymphocytic Leukemia?
Please visit:

CLLS is a patient–centric, physician–curated nonprofit organization focused on patient education, support and research dedicated to addressing the unmet needs of the CLL (chronic lymphocytic leukemia) community.